1. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study
2. European Medicines Agency (EMA)(2020).https://www.ema.europa.eu/en(accessed 22 March 2020).
3. Guidance for Industry ICH M4: Organization of the CTD(2001)U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER)https://www.fda.gov/cber/gdlns/m4ctd.pdf.
4. Junod S.W.(2014).US Food and Drug Administration.https://www.fda.gov/media/110437/download.